Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...

Wall Street’s main indices finished in the green but with lackluster gains, with the Nasdaq rising 0.27 percent, the S&P 500 ...

Markets enter the week on edge as Q2 earnings season kicks off with heavyweight banks and global blue chips. Investors will ...

BHUBANESWAR: The Higher Education department on Monday directed all the universities and colleges in the state to submit compliance report on internal committee ...

The Unusual Effects Of Anavex's Blarcamesine On Alzheimer's Disease (Upgrade) SA analyst upgrades: NVDA, MAIN, ALB, APP, QBTS, HIMS (Update) Anavex Life Sciences GAAP EPS of -$0.13 beats by $0.02 ...

SO Britain’s second-least worst prince is on manoeuvres. Prince Andrew’s nephew, Harry, has been quietly negotiating behind ...

WW International relists on Nasdaq, pivoting to menopause care with GLP-1 drugs and coaching. Click here to read an analysis ...

We came across a bearish thesis on Hims & Hers on FJ Research’s Substack. As of 3ʳᵈ July, Hims & Hers’s share was trading at ...

President Donald Trump will announce $70 billion in artificial intelligence and energy investments in Pennsylvania on Tuesday, as part of White House efforts to accelerate development of emerging ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Amid the outrage over the self-immolation attempt by a student of FM Autonomous College in Balasore, the Odisha Higher Ed ...

Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...